Inventor · disambiguated record
Birgitt Schneider
Also filed as: REDDERSEN GUDRUN · SCHNEIDER BIRGITT
16 granted patents·5 pending applications·235 citations·filing 1993–2008
93Inventor score
Top patents by PatentIndex Score
21 records- 0196US7534780B2Estradiol prodrugsBAYER SCHERING PHARMA AG·Filed 2005·Granted May 19, 2009·59 cites·26 claims
- 0281US6825182B217α-fluoroalkyl-11β-benzaldoxime steroids, process for their production, pharmaceutical preparations that contain these steroids as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 2003·Granted Nov 30, 2004·17 cites·10 claims
- 0380US6841548B2Pharmaceutical preparations containing estra-1,3,5(10)-triene derivativesSCHERING AG·Filed 2001·Granted Jan 11, 2005·14 cites·3 claims
- 0479US6583130B1C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compoundsSCHERING AG·Filed 2000·Granted Jun 24, 2003·18 cites·8 claims
- 0579US6388109B114,15-cyclopropano steroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compoundsJENAPHARM GMBH·Filed 1999·Granted May 14, 2002·53 cites·5 claims
- 0676US7550451B2Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapyBAYER SCHERING PHARMA AG·Filed 2003·Granted Jun 23, 2009·10 cites·24 claims
- 0773US6436917B1Non-estrogenic estradiol derivative compounds with anti-oxidative activityJENAPHARM GMBH·Filed 1998·Granted Aug 20, 2002·25 cites·5 claims
- 0869US7419972B22-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1SCHERING AG·Filed 2005·Granted Sep 2, 2008·2 cites·26 claims
- 0968US5705495ASulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compoundsJENAPHARM GMBH·Filed 1996·Granted Jan 6, 1998·25 cites·3 claims
- 1060US7732493B22-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1BAYER SCHERING PHARMA AG·Filed 2008·Granted Jun 8, 2010·0 cites·13 claims
- 1150US7435757B22-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1SCHERING AG·Filed 2005·Granted Oct 14, 2008·0 cites·13 claims
- 1250US6569844B1Pharmaceutical preparations containing estra-1,3,5(10)-triene derivativesJENAPHARM GMBH·Filed 1995·Granted May 27, 2003·8 cites·4 claims
- 1350US2003130249A1Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy)SCHERING AG·Filed 2002·Application pending·0 cites
- 1447US7199115B217α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making themSCHERING AG·Filed 2005·Granted Apr 3, 2007·0 cites·8 claims
- 1546US7388003B2Δ15-D-Homosteroids with androgenic actionBAYER SCHERING PHARMA AG·Filed 2004·Granted Jun 17, 2008·0 cites·21 claims
- 1644US2002065258A1Non-estrogenic estradiol derivative compounds with antioxidative activityFiled 2001·Application pending·0 cites
- 1743US2005277625A1Estriol and estetrol prodrugsWYRWA RALF·Filed 2005·Application pending·0 cites
- 1843US2005282793A1Steroid prodrugs with androgenic actionWYRWA RALF·Filed 2005·Application pending·0 cites
- 1939US5614213AUse of estriol for treatment of climacteric osteoporosisENTEC·Filed 1993·Granted Mar 25, 1997·4 cites·4 claims
- 2036US2004067923A1Use of biogenic estriol sulfamate prodrugs for treatment of autoimmune diseasesFiled 2003·Application pending·0 cites
- 2129US6534490B1Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compoundsJENAPHARM GMBH·Filed 1999·Granted Mar 18, 2003·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Birgitt Schneider files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →